Skip to content


  • Oral presentation
  • Open Access

Induction of HIV-specific T-cell responses by gag

  • 1,
  • 1,
  • 1,
  • 1 and
  • 2
Retrovirology20063 (Suppl 1) :S78

  • Published:


  • Peptide
  • Infectious Disease
  • Cancer Research
  • Treated Subject
  • Delay Evolution


In order to suppress HIV and delay evolution to AIDS, antigen-loaded DC might be useful to boost and broaden HIV-1-specific T-cell responses, which are dysfunctional in HIV infection.


DC (from 15 treatment-naïve and 15 HAART-treated HIV-1-infected patients) were electroporated with codon-optimized mRNA encoding consensus HxB-2 Gag. These DC were co-cultured for 1 week with autologous peripheral blood leucocytes. Expansion of specific T-cells was measured by ELISPOT, using a pool of overlapping peptides, spanning HxB-2 Gag.


Expansion of specific T cells producing IFN-γ, IL-2 and perforin was seen. Comparing the response between 12 treated and 12 naïve patients, matched in absolute CD4+ T-cell count, showed that the response was higher in treated subjects for IFN-γ and IL-2 but not for perforin. HxB-2 peptides induced IFN-γ in CD4+ and CD8+ T-cell subsets purified following coculture, IL-2 was only secreted by CD4+ T-cells and perforin was dominantly secreted by CD8+ T-cells. Remarkably, the perforin response in naïve persons was negatively correlated with the absolute CD4+ and CD8+ T-cell count. The nadir CD4+ T-cell count in treated subjects was positively correlated with the IL-2 response and negatively correlated with the perforin response.


HxB-2 gag mRNA-transfected DC from treated and naïve subjects have the capacity to induce secondary T-cell responses. These results of this and another study, where we showed that T-cells from naïve HIV-infected subjects can be triggered by DC electroporated with autologous gag mRNA (Blood 2006;107:1818-27), open the perspective for a DC immunotherapy of HIV disease.

Authors’ Affiliations

Institute of Tropical Medicine, Antwerp, Belgium
Antwerp University Hospital, Antwerp University, Antwerp, Belgium


© Van Gulck et al; licensee BioMed Central Ltd. 2006

This article is published under license to BioMed Central Ltd.